Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to $1.5 million.
- Viridian Therapeutics, Inc.\DE's Other Non-Current Assets rose 7796.01% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 7796.01%. This contributed to the annual value of $501000.0 for FY2024, which is 1705.3% down from last year.
- Latest data reveals that Viridian Therapeutics, Inc.\DE reported Other Non-Current Assets of $1.5 million as of Q3 2025, which was up 7796.01% from $506000.0 recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets registered a high of $1.5 million during Q1 2022, and its lowest value of $1000.0 during Q1 2021.
- In the last 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets had a median value of $982000.0 in 2022 and averaged $912947.4.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 15410000.0% in 2022, then plummeted by 4434.12% in 2024.
- Quarter analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Other Non-Current Assets stood at $1.5 million in 2021, then tumbled by 34.14% to $982000.0 in 2022, then crashed by 38.49% to $604000.0 in 2023, then fell by 17.05% to $501000.0 in 2024, then surged by 202.99% to $1.5 million in 2025.
- Its Other Non-Current Assets was $1.5 million in Q3 2025, compared to $506000.0 in Q2 2025 and $489000.0 in Q1 2025.